By Nick Maosa, Research Coordinator

Groundbreaking evidence on the role of digital health in strengthening HIV prevention and maternal care was unveiled during the KASH Conference 2026, held from February 10–13 at the Safari Park Hotel in Nairobi. Organized by the Kenya Medical Research Institute (KEMRI), the conference brought together leading scientists, innovators, and policymakers to discuss advancements aligned with the theme Scientific Research, Innovations, Technologies and Manufacturing for a Resilient Universal Health Coverage (UHC).

A major highlight of the conference from among the abstracts presented by the Global Health Innovation – GHI, was the presentation of a cluster-randomized trial evaluating the HIV Infant Tracking System (HITSystem v2.1)—an eHealth innovation designed to improve retention and guideline-adherent viral load monitoring within prevention of mother-to-child transmission (PMTCT) programs.

Digital Health Innovation Demonstrates Significant Impact on PMTCT Outcomes

Researchers presented evidence from a rigorously conducted trial across 12 public hospitals in Siaya, Kilifi, and Mombasa counties. The study enrolled 1,639 pregnant women living with HIV between October 2020 and January 2023, with 1,396 participants included in the final analysis.

The HITSystem v2.1, featuring automated provider alerts and client SMS reminders, was evaluated against standard of care. The system demonstrated clear benefits:

1. – Women in HITSystem-supported facilities were twice as likely to complete all required PMTCT services from the first antenatal visit to six months postpartum (8% vs 4%; aOR 2.4).

1. – A sensitivity analysis—excluding infant testing <7 weeks—confirmed a sustained two fold improvement (20% vs 10%; aOR 2.6).

1. – Guideline-adherent antenatal viral load testing was significantly higher in HITSystem sites (58% vs 36%, aOR 2.5).

1. – Postpartum viral load testing (68% vs 59%) and clinical action on unsuppressed results (79% vs 63%) were also higher, though not statistically significant.

1. – Viral suppression rates at delivery (93% vs 92%) and at six months postpartum (88% vs 82%) remained comparable across arms.

1. – Eight infants were diagnosed with HIV, reflecting a low 0.5% overall transmission rate.

Despite COVID-19 disruptions and nationwide reagent shortages due to the diming PEPFAR funding towards the end of the 5-year funding cycle, the study reported no adverse events, reinforcing the system’s safety and scalability.

Positioning Innovation at the Heart of Resilient UHC

The findings underscore the critical role of locally implemented digital technologies in strengthening health systems. By enhancing PMTCT retention, improving viral load monitoring, and supporting timely clinical action, HITSystem 2.1 exemplifies the type of innovation required to sustain Kenya’s progress toward UHC.

Presenters emphasized that digital health tools:

1. – Bridge gaps in continuity of care

1. – Support frontline health workers with real-time decision prompts

1. – Improve patient follow-up and service uptake

1. – Offset systemic challenges such as staffing shortages and supply chain disruptions

The trial’s success, occurring amid a global pandemic and logistics constraints, signals Kenya’s growing capacity to integrate resilient, technology-driven solutions within routine maternal and HIV care.

Strengthening Local Research and Technology Ecosystems

The presentation aligned strongly with the conference’s focus on science-driven innovation and local manufacturing as pillars for a robust health system. Delegates noted that sustained investment in research and development—as seen in the HITSystem study—continues to position Kenya as a continental leader in digital health transformation.

The research team highlighted the potential for national scale-up of the HITSystem, given its compatibility with Kenya’s evolving digital health architecture and UHC roadmap.

Conclusion

The evidence presented at KASH Conference 2026 demonstrates that digital innovations like the HITSystem v2.1 are instrumental in advancing resilient UHC in Kenya. By strengthening PMTCT outcomes, streamlining viral load monitoring, and supporting data-driven decision-making, such tools provide a clear pathway toward eliminating perinatal HIV transmission and enhancing maternal health outcomes nationwide.

As Kenya accelerates its UHC agenda, scientific research and technological innovation remain central to ensuring accessible, efficient, and equitable healthcare for all.